Scripps Research identifies binding site on challenging cancer protein

Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein called Forkhead box protein 1 (FOXA1). FOXA1 mutations can enable these types of cancers to grow and proliferate.

Drug shortages challenge type 2 diabetes patients in the UK – Pharmaceutical Technology

Share this article GLP-1 receptor agonists mimic the hormone GLP-1 which controls blood sugar levels. Credit: Alan Sau via Shutterstock. Drug shortages are continuing to

January 28, 2024

Parkinson’s disease may be helped by GLP-1 drug, new study finds

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective for diabetes and obesity, but is also showing early potential

April 3, 2024

TLM-101 by Therillume for Neurofibromatoses Type I (Von Recklinghausen’s Disease): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.